180 related articles for article (PubMed ID: 27487944)
1. The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors.
Ikawa Y; Uchiyama T; Jagadeesh GJ; Candotti F
Gene Ther; 2016 Nov; 23(11):815-818. PubMed ID: 27487944
[TBL] [Abstract][Full Text] [Related]
2. Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.
Bosticardo M; Ghosh A; Du Y; Jenkins NA; Copeland NG; Candotti F
Mol Ther; 2009 Nov; 17(11):1910-8. PubMed ID: 19638958
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.
Moiani A; Miccio A; Rizzi E; Severgnini M; Pellin D; Suerth JD; Baum C; De Bellis G; Mavilio F
PLoS One; 2013; 8(1):e55721. PubMed ID: 23383272
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of retroviral long terminal repeats on interleukin-3 gene expression and autocrine transformation.
Wang XY; McCubrey JA
Leukemia; 1997 Oct; 11(10):1711-25. PubMed ID: 9324293
[TBL] [Abstract][Full Text] [Related]
5. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
6. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice.
Kaneko S; Onodera M; Fujiki Y; Nagasawa T; Nakauchi H
Hum Gene Ther; 2001 Jan; 12(1):35-44. PubMed ID: 11177540
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter.
Vile RG; Diaz RM; Miller N; Mitchell S; Tuszyanski A; Russell SJ
Virology; 1995 Dec; 214(1):307-13. PubMed ID: 8525635
[TBL] [Abstract][Full Text] [Related]
8. Reduced genotoxicity of avian sarcoma leukosis virus vectors in rhesus long-term repopulating cells compared to standard murine retrovirus vectors.
Hu J; Renaud G; Gomes TJ; Ferris A; Hendrie PC; Donahue RE; Hughes SH; Wolfsberg TG; Russell DW; Dunbar CE
Mol Ther; 2008 Sep; 16(9):1617-23. PubMed ID: 18578011
[TBL] [Abstract][Full Text] [Related]
9. Retroviral vector design for long-term expression in murine hematopoietic cells in vivo.
Correll PH; Colilla S; Karlsson S
Blood; 1994 Sep; 84(6):1812-22. PubMed ID: 8080986
[TBL] [Abstract][Full Text] [Related]
10. Establishment of modified retroviral vector targeting X-linked severe combined immunodeficiency.
Zhi CL; Migita M; Hayakawa J; Fukunaga Y
J Nippon Med Sch; 2004 Feb; 71(1):51-6. PubMed ID: 15129596
[TBL] [Abstract][Full Text] [Related]
11. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
Junker U; Böhnlein E; Veres G
Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
[TBL] [Abstract][Full Text] [Related]
12. High-resolution analysis of cytosine methylation in the 5ĺong terminal repeat of retroviral vectors.
Wang L; Robbins PB; Carbonaro DA; Kohn DB
Hum Gene Ther; 1998 Nov; 9(16):2321-30. PubMed ID: 9829531
[TBL] [Abstract][Full Text] [Related]
13. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.
Rivière I; Brose K; Mulligan RC
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6733-7. PubMed ID: 7624312
[TBL] [Abstract][Full Text] [Related]
14. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells.
Challita PM; Skelton D; el-Khoueiry A; Yu XJ; Weinberg K; Kohn DB
J Virol; 1995 Feb; 69(2):748-55. PubMed ID: 7815539
[TBL] [Abstract][Full Text] [Related]
15. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.
Challita PM; Kohn DB
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2567-71. PubMed ID: 8146155
[TBL] [Abstract][Full Text] [Related]
16. The U3 region of Moloney murine leukemia virus contains position-independent cis-acting sequences involved in the nuclear export of full-length viral transcripts.
Volkova NA; Fomina EG; Smolnikova VV; Zinovieva NA; Fomin IK
J Biol Chem; 2014 Jul; 289(29):20158-69. PubMed ID: 24878957
[TBL] [Abstract][Full Text] [Related]
17. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
[TBL] [Abstract][Full Text] [Related]
18. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity.
Modlich U; Bohne J; Schmidt M; von Kalle C; Knöss S; Schambach A; Baum C
Blood; 2006 Oct; 108(8):2545-53. PubMed ID: 16825499
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Moloney leukemia virus long terminal repeat transcriptional activity by the murine CD4 silencer in retroviral vectors.
Indraccolo S; Minuzzo S; Habeler W; Zamarchi R; Fregonese A; Günzburg WH; Salmons B; Uckert W; Chieco-Bianchi L; Amadori A
Virology; 2000 Oct; 276(1):83-92. PubMed ID: 11021997
[TBL] [Abstract][Full Text] [Related]
20. Retroviral-mediated gene expression in human myelomonocytic cells: a comparison of hematopoietic cell promoters to viral promoters.
Malik P; Krall WJ; Yu XJ; Zhou C; Kohn DB
Blood; 1995 Oct; 86(8):2993-3005. PubMed ID: 7579392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
